Investor Relations

Press Releases

PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 10:55 a.m. Eastern time. Dr. Aklog will provide a corporate overview, discuss the Company’s innovative business model and review PAVmed’s lead products. The conference is taking place at the InterContinental New York Barclay Hotel in New York City on September 25-27, 2017.

To access the live webcast of the presentation, please click here. A replay will be available following the presentation.

About PAVmed Inc.

PAVmed Inc. (Nasdaq: PAVM, PAVMW) is a highly differentiated, multi-product medical device company employing a unique business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding multi-product pipeline strategy with a view to enhancing and accelerating value creation. PAVmed’s diversified pipeline of products address unmet clinical needs, have attractive regulatory pathways and market opportunities and encompass a broad spectrum of clinical areas including carpal tunnel syndrome (CarpX™), medical infusions (NextFlo™ and NextCath™), interventional radiology (PortIO™ and NextCath), tissue ablation and cardiovascular intervention (Caldus™) and pediatric ear infections (DisappEAR™).



LHA Investor Relations
Kim Sutton Golodetz, 212-838-3777
Rooney Partners
Kate Barrette, 212-223-0561


Source: PAVmed Inc.

Released September 18, 2017